Journals / Turkish Journal of Gastroenterology / 2010 / Cilt: 21 - Sayı: 1

Helikobakter pilori pozitif nonülser dispepsili hastalarda birinci basamak tedavide levofloksasin içeren üçlü tedavinin 7 ve 14 günlük etkinliğinin karşılaştırılması

Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia

Pages
12–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Triple therapy with lansoprazole, levofloxacin and amoxicillin for 14 days was effective for Helicobacter pylori eradication, but 7-day therapy with the same protocol had a lower and unacceptable cure rate and should not be used.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Because of the increasing resistance to clarithromycin and metronidazole, the most frequently used antibiotics in the first-line therapy of Helicobacter pylori eradication, new therapeutic alternatives are needed.
📊
Key Findings & Data:The aim of this study was to compare the efficacy of 7- and 14-day triple therapy including lansoprazole, levofloxacin and amoxicillin for Helicobacter pylori eradication as a first-line therapy.
💡
Conclusion & Impact:Conclusions: Triple therapy with lansoprazole, levofloxacin and amoxicillin for 14 days was effective for Helicobacter pylori eradication, but 7-day therapy with the same protocol had a lower and unacceptable cure rate and should not be used.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dispepsi · Anti-enfektif ajanlar · İlaç tedavisi

Abstract

Because of the increasing resistance to clarithromycin and metronidazole, the most frequently used antibiotics in the first-line therapy of Helicobacter pylori eradication, new therapeutic alternatives are needed. The aim of this study was to compare the efficacy of 7- and 14-day triple therapy including lansoprazole, levofloxacin and amoxicillin for Helicobacter pylori eradication as a first-line therapy. Methods: Ninety-one non-ulcer dyspeptic patients infected with Helicobacter pylori as diagnosed by both histology and a rapid urease test were included in this study. Patients were randomized to receive either 7- (Group 1; 51 patients) or 14-day (Group 2; 40 patients) therapy with lansoprazole (30 mg b.i.d.), plus levofloxacin (500 mg o.i.d.) and amoxicillin (1000 mg b.i.d.) and they were followed for six weeks. Eradication was assessed by 14C-urea breath test four weeks after completing the treatment protocols. Results: In Group 1, 41 patients completed the treatment and the eradication rate was 34.15%. In group 2, 36 patients completed the treatment and the eradication rate was 72.2% (p= 0.001 vs group 1). Conclusions: Triple therapy with lansoprazole, levofloxacin and amoxicillin for 14 days was effective for Helicobacter pylori eradication, but 7-day therapy with the same protocol had a lower and unacceptable cure rate and should not be used.

Özet

Birinci basamak Helikobakter pilori eradikasyon tedavisinde en sık kullanılan antibiyotikler olan klaritromisin ve metranidazole direncin artması nedeniyle, yeni tedavi alternatiflerine ihtiyaç duyulmaktadır. Bu çalışmanın amacı; birinci basamak eradikasyon tedavisinde lansoprazol, levofloksasin ve amoksisilin'den oluşan üçlü tedavi protokolünün 7 ve 14 günlük etkinliğinin karşılaştırılmasıdır. Yöntem: Histoloji ve hızlı üreaz testi ile Helikobakter pilori varlığı gösterilmiş nonülser dispepsili 91 hasta çalışmaya alındı. Hastalar 7 günlük (Grup 1: 51 hasta) ve 14 günlük (Grup 2: 40 hasta) lansoprazol 30 mg (2x1), levofloksasin 500 mg (1x1) ve amoksisilin 1000 mg (2x1) tedavisi alacak şekilde randomize edildi ve 6 hafta süre ile izlendi. Eradikasyon, tedavi bitiminden 4 hafta sonra üre nefes testi ile değerlendirildi. Bulgular: Grup 1 hastalarının 41'i çalı şmayı tamamladı ve eradikasyon oranı %34.15 idi. Grup 2'de ise 38 hasta çalışmayı tamamladı ve eradikasyon oranı %72.22 idi. 7 ve 14 günlük tedaviler arasında eradikasyon oranı açısından anlamlı bir fark tespit edildi (p= 0.001). Sonuç: Ondört gün süreyle uygulanan lansoprazol, levofloksasin ve amoksisilinden oluşan üçlü protokol, Helikobakter pilori eradikasyonunda etkilidir, ancak 7 günlük tedavide eradikasyon oranı çok düşüktür ve kullanılmamalıdır.

🔖

Cite This Article

ERÇİN, C. N., UYGUN, A., TOROS, A. B., KANTARCIOĞLU, M., KİLCİLER, G., POLAT, Z., BAĞCI, S. (2010). Helikobakter pilori pozitif nonülser dispepsili hastalarda birinci basamak tedavide levofloksasin içeren üçlü tedavinin 7 ve 14 günlük etkinliğinin karşılaştırılması. Turkish Journal of Gastroenterology, Cilt: 21 - Sayı: 1, 12–16. https://ajindex.com/articles/409784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81
  2. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12
  3. Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents-- an evidence-based evaluation. Can J Gastroenterol 2005; 19: 399-408
  4. Malfertheiner P, Bayerdörffer E, Diete U, et al. The GUMACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 13: 703-12
  5. Zanten SJ, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289-95
  6. Gisbert JP, Khorrami S, Calvet X, Pajares JM. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2004; 16: 89-99
  7. Baños F, Madridejos R, Cabezas C, et al. Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study. Med Clin (Barc) 2000; 114: 441-3
  8. Palmas F, Pellicano R, Massimetti E, et al. Eradication of Helicobacter pylori infection with proton pump inhibitorbased triple therapy. A randomised study. Panminerva Med 2002; 44: 145-7
  9. Ayd'n A, Faik G, Onder F, et al. The effectiveness of ranitidine bismuth citrate-amoxicillin-clarithromycin combination in eradication of HP in clarithromycin-resistant and - sensitive cases [Abstract]. Turk J Gastroenterol 2004 (Suppl): 57
  10. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006; 28: 1960-6
  11. Bock H, Koop H, Lehn N, Heep M. Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience. J Clin Gastroenterol 2000; 31: 222-5
  12. Perri F, Festa V, Clemente R, et al. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharma